litlas
ログインアカウント作成

Miyuki Azuma

1990–2026 年に発表

104
論文数
23,334
被引用数
81
h 指数
103
i10 指数

被引用数

Miyuki Azuma の年別被引用数1950 年: 被引用 1 件1992 年: 被引用 8 件1993 年: 被引用 21 件1994 年: 被引用 85 件1995 年: 被引用 133 件1996 年: 被引用 157 件1997 年: 被引用 142 件1998 年: 被引用 116 件1999 年: 被引用 161 件2000 年: 被引用 116 件2001 年: 被引用 102 件2002 年: 被引用 66 件2003 年: 被引用 96 件2004 年: 被引用 137 件2005 年: 被引用 160 件2006 年: 被引用 183 件2007 年: 被引用 213 件2008 年: 被引用 234 件2009 年: 被引用 210 件2010 年: 被引用 254 件2011 年: 被引用 232 件2012 年: 被引用 251 件2013 年: 被引用 271 件2014 年: 被引用 283 件2015 年: 被引用 349 件2016 年: 被引用 393 件2017 年: 被引用 395 件2018 年: 被引用 292 件2019 年: 被引用 776 件2020 年: 被引用 841 件2021 年: 被引用 810 件2022 年: 被引用 516 件2023 年: 被引用 352 件2024 年: 被引用 538 件2025 年: 被引用 207 件2026 年: 被引用 6 件1951〜1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,130 件、この内訳の 32.2%中国: 引用元論文 1,280 件、この内訳の 13.2%日本: 引用元論文 665 件、この内訳の 6.9%ドイツ: 引用元論文 504 件、この内訳の 5.2%イギリス: 引用元論文 500 件、この内訳の 5.2%フランス: 引用元論文 383 件、この内訳の 3.9%イタリア: 引用元論文 364 件、この内訳の 3.7%カナダ: 引用元論文 260 件、この内訳の 2.7%オーストラリア: 引用元論文 231 件、この内訳の 2.4%スイス: 引用元論文 204 件、この内訳の 2.1%オランダ: 引用元論文 178 件、この内訳の 1.8%韓国: 引用元論文 168 件、この内訳の 1.7%
0%32.2%その他 19%

機関

分野

  • Medicine45.2%
  • Immunology and Microbiology36.3%
  • Biochemistry, Genetics and Molecular Biology12.8%
  • Neuroscience3%
  • Dentistry0.8%
  • Psychology0.5%
  • その他1.4%

トピック

  • Cancer Immunotherapy and Biomarkers12.1%
  • Immune Cell Function and Interaction12%
  • Immunotherapy and Immune Responses9.2%
  • T-cell and B-cell Immunology7.2%
  • CAR-T cell therapy research4.7%
  • Immune cells in cancer2.4%
  • その他52.4%

共著者

全論文

検索で開く
  1. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2

    著者: Tadashi Yokosuka, Masako Takamatsu, Wakana Kobayashi-Imanishi, Akiko Hashimoto, Miyuki Azuma, Takashi Saito - The Journal of Experimental Medicine 2012 被引用: 1,156

  2. Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia

    著者: Qing Zhou, Meghan E. Munger, Rachelle G. Veenstra, Brenda J. Weigel, Mitsuomi Hirashima, David H. Munn, William J. Murphy, Miyuki Azuma, Ana C. Anderson, Vijay K. Kuchroo, Bruce R. Blazar - Blood 2011 被引用: 679

  3. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation

    著者: M. NAKAYAMA, Hisaya Akiba, Kazuyoshi Takeda, Yuko Kojima, Masaaki Hashiguchi, Miyuki Azuma, Hideo Yagita∥, Ko Okumura - Blood 2009 被引用: 424

  4. VISTA expressed in tumour cells regulates T cell function

    著者: Kumuluzi Mulati, Junzo Hamanishi, Noriomi Matsumura, Kenji Chamoto, Nathan Mise, Kaoru Abiko, Tsukasa Baba, Ken Yamaguchi, Naoki Horikawa, Ryusuke Murakami, Mana Taki, Budiman Kharma, Xiang Zeng, Yuko Hosoe, Miyuki Azuma, Ikuo Konishi, Masaki Mandai - British Journal of Cancer 2018 被引用: 205

  5. Expression of Programmed Death 1 Ligands by Murine T Cells and APC

    著者: Tomohide Yamazaki, Hisaya Akiba, Hideyuki Iwai, Hironori Matsuda, Mami Aoki, Yuka Tanno, Tahiro Shin, Haruo Tsuchiya, Drew M. Pardoll, Ko Okumura, Miyuki Azuma, Hideo Yagita∥ - The Journal of Immunology 2002 被引用: 946

  6. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal

    著者: Brian T. Fife, Kristen E. Pauken, Todd N. Eagar, Takashi Obu, Jenny Wu, Qizhi Tang, Miyuki Azuma, Matthew F. Krummel, Jeffrey A. Bluestone - Nature Immunology 2009 被引用: 743

  7. The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice

    著者: Mohammed Javeed Ansari, Alan D. Salama, Tanuja Chitnis, R. Neal Smith, Hideo Yagita∥, Hisaya Akiba, Tomohide Yamazaki, Miyuki Azuma, Hideyuki Iwai, Samia J. Khoury, Hugh Auchincloss, Mohamed H. Sayegh - The Journal of Experimental Medicine 2003 被引用: 807

  8. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

    著者: Madhav Sharma, Babak Baban, Phillip Chandler, De-Yan Hou, Nagendra Singh, Hideo Yagita∥, Miyuki Azuma, Bruce R. Blazar, Andrew L. Mellor, David H. Munn - Journal of Clinical Investigation 2007 被引用: 772

  9. Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade

    著者: Emi Kawada-Horitani, Shunbun Kita, Tomonori Okita, Yuto Nakamura, Hiroyuki Nishida, Yoichi Honma, Shiro Fukuda, Yuri Tsugawa-Shimizu, Junji Kozawa, Taka‐aki Sakaue, Yusuke Kawachi, Yuya Fujishima, Hitoshi Nishizawa, Miyuki Azuma, Norikazu Maeda, Iichiro Shimomura - Diabetologia 2022 被引用: 67

  10. Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma

    著者: Yuta Kondo, Tatsukuni Ohno, Naoto Nishii, Kiyoshi Harada, Hideo Yagita∥, Miyuki Azuma - Oral Oncology 2016 被引用: 141

  11. B70 antigen is a second ligand for CTLA-4 and CD28

    著者: Miyuki Azuma, Daisuke Ito, Hideo Yagita∥, Ko Okumura, Joseph H. Phillips, Lewis L. Lanier, Chamorro Somoza - Nature 1993 被引用: 917

  12. How Two Brains Make One Synchronized Mind in the Inferior Frontal Cortex: fNIRS-Based Hyperscanning During Cooperative Singing

    著者: Naoyuki Osaka, Takehiro Minamoto, Ken Yaoi, Miyuki Azuma, Yohko Shimada, Mariko Osaka - Frontiers in Psychology 2015 被引用: 166

  13. Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses

    著者: Masaaki Hashiguchi, Hiroko Kobori, Patcharee Ritprajak, Yosuke Kamimura, Haruo Kozono, Miyuki Azuma - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 被引用: 223

  14. Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma

    著者: Patcharee Ritprajak, Miyuki Azuma - Oral Oncology 2014 被引用: 311

  15. Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer

    著者: Takeo Nomi, Masayuki Sho, Takahiro Akahori, Kaoru Hamada, Atsushi Kubo, Hiromichi Kanehiro, Shinji Nakamura, Koji Enomoto, Hideo Yagita∥, Miyuki Azuma, Yoshiyuki Nakajima - Clinical Cancer Research 2007 被引用: 897

  16. Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers

    著者: Juro Nakanishi, Yoshihiro Wada, Koichiro Matsumoto, Miyuki Azuma, Ken Kikuchi, Shoichi Ueda - Cancer Immunology Immunotherapy 2006 被引用: 474

  17. Critical Role of the Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune Encephalomyelitis

    著者: Alan D. Salama, Tanuja Chitnis, Jaime Imitola, Mohammed Javeed Ansari, Hisaya Akiba, Fumihiko Tushima, Miyuki Azuma, Hideo Yagita∥, Mohamed H. Sayegh, Samia J. Khoury - The Journal of Experimental Medicine 2003 被引用: 507

  18. A critical role for the programmed death ligand 1 in fetomaternal tolerance

    著者: Indira Guleria, Arezou Khosroshahi, Mohammed Javeed Ansari, Antje Habicht, Miyuki Azuma, Hideo Yagita, Randolph J. Noelle, Anthony J. Coyle, Andrew L. Mellor, Samia J. Khoury, Mohamed H. Sayegh - The Journal of Experimental Medicine 2005 被引用: 426

  19. An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers

    著者: Hideaki Morita, Ken Arae, Hirotoshi Unno, Kousuke Miyauchi, Sumika Toyama, Aya Nambu, Keisuke Oboki, Tatsukuni Ohno, Kenichiro Motomura, Akira Matsuda, Sachiko Yamaguchi, Seiko Narushima, Naoki Kajiwara, Motoyasu Iikura, Hajime Suto, Andrew N. J. McKenzie, Takao Takahashi, Hajime Karasuyama, Ko Okumura, Miyuki Azuma, Kazuyo Moro, Cezmi A. Akdiş, Stephen J. Galli, Shigeo Koyasu, Masato Kubo, Katsuko Sudo, Hirohisa Saito, Kenji Matsumoto, Susumu Nakae - Immunity 2015 被引用: 265

  20. Differential binding properties of B7-H1 and B7-DC to programmed death-1

    著者: Pornpan Youngnak, Yuko Kozono, Haruo Kozono, Hideyuki Iwai, Noriko Otsuki, Hisayo Jin, Ken Omura, Hideo Yagita∥, Drew M. Pardoll, Lieping Chen, Miyuki Azuma - Biochemical and Biophysical Research Communications 2003 被引用: 205

  21. Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer

    著者: Yuichiro Ohigashi, Masayuki Sho, Yukishige Yamada, Yoshikazu Tsurui, Kaoru Hamada, Naoya Ikeda, Takashi Mizuno, Ryo Yoriki, Hisanori Kashizuka, Katsunari Yane, Fumihiko Tsushima, Noriko Otsuki, Hideo Yagita∥, Miyuki Azuma, Yoshiyuki Nakajima - Clinical Cancer Research 2005 被引用: 792

  22. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway

    著者: Brian T. Fife, Indira Guleria, Melanie Gubbels Bupp, Todd N. Eagar, Qizhi Tang, H Bour, Hideo Yagita∥, Miyuki Azuma, Mohamed H. Sayegh, Jeffrey A. Bluestone - The Journal of Experimental Medicine 2006 被引用: 323

  23. Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia

    著者: Qing Zhou, Meghan E. Munger, Steven L. Highfill, Jakub Tolar, Brenda J. Weigel, Megan Riddle, Arlene H. Sharpe, Daniel A. Vallera, Miyuki Azuma, Bruce L. Levine, Carl H. June, William J. Murphy, David H. Munn, Bruce R. Blazar - Blood 2010 被引用: 285

  24. PDL1 Is Required for Peripheral Transplantation Tolerance and Protection from Chronic Allograft Rejection

    著者: Katsunori Tanaka, Monica J. Albin, Xueli Yuan, K. Yamaura, Antje Habicht, Takaya Murayama, Martin Grimm, Ana Maria Waaga, Takuya Ueno, Robert F. Padera, Hideo Yagita∥, Miyuki Azuma, Tahiro Shin, Bruce R. Blazar, David M. Rothstein, Mohamed H. Sayegh, Nader Najafian - The Journal of Immunology 2007 被引用: 204